Endothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy

The obstacle in delivering therapeutics to glioblastoma (GBM) is tumor-induced angiogenesis which leads to the formation of abnormal vessels and a dysfunctional blood-tumor barrier. Here, we elucidated the effect of endothelial-monocyte activating polypeptide II (EMAP II) on the GBM-induced angiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiqing, Ma, Jun, Liu, Libo, Liu, Xiaobai, Wang, Ping, Liu, Yunhui, Li, Zhen, Zheng, Jian, Chen, Jiajia, Tao, Wei, Xue, Yixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488748/
https://www.ncbi.nlm.nih.gov/pubmed/28701921
http://dx.doi.org/10.3389/fnmol.2017.00208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488748/
https://www.ncbi.nlm.nih.gov/pubmed/28701921
http://dx.doi.org/10.3389/fnmol.2017.00208

Ejemplares similares